Infectious disease patent intelligence

US 6420336

Methods of using cyanovirins topically to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6413938

Benzimidazole derivatives for the treatment of viral infections

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6413944

Triciribine and analogs as antiviral drugs

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410012

Antimicrobial mediated bacterial DNA delivery

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410056

Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6406887

Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399332

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399062

Murine monoclonal antibody protective against Plasmodium vivax malaria

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6387662

Synthesis and purification of hepatitis C virus-like particles

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6387959

Antiviral therapy

Universitair Medisch Centrum Utrecht · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6384015

Selective lysis of malaria infected erythrocytes

The Regents of the University of California · Granted Tue May 07 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6379891

Method of detecting HEV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6372455

Recombinant vaccinia viral vectors

THE ARIZONA BOARD OF REGENTS · Granted Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6372217

Methods for the treatment of CD7+ viral infection with TXU-7-PAP

Regents of the University of Minnesota · Granted Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6369101

Therapeutic method to treat herpes virus infection

Regents of the University of Minnesota · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6369235

Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6365401

Method and probes for the identification of microbial genes specifically induced during host infection

The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6355790

Inhibition of HIV replication using a mutated transfer RNA primer

The Regents of the University of California · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6352991

2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6347633

Treatment of hepatitis C using hyperthermia

First Circle Medical, Inc. · Granted Tue Feb 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6342501

Pyrrolo[2,3-d] pyrimidines as antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6323019

Design of novel highly efficient HIV based packaging systems for gene therapy

The Regents of the University of California · Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6323185

Anti-viral guanosine-rich oligonucleotides and method of treating HIV

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6319904

Formulation comprising antibacterial substance and antiulcer substance

Takeda Chemical Industries Ltd. · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6316190

Oligonucleotides which specifically bind retroviral nucleocapsid proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6313090

Methods for treating parasitic infection using thiopeptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6313178

Use of hexahydrolupulones as antibacterial and anticancer agents

Regents of the University of Minnesota · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6309669

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6305380

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6303334

Nucleic acid encoding a transdominant negative retroviral integrase

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6297004

Recombinant viruses displaying a nonviral polypeptide on their external surface

Cambridge Drug Discovery Holding, LTD · Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6294322

Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6290963

Anti-HIV compositions containing native and recombinant peptides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6291431

Methods and compositions for the treatment and prevention of Staphylococcal infections

The Regents of the University of California · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6291637

Interference with viral IRES-mediated translation by a small yeast RNA reveals critical RNA-protein interactions

The Regents of the University of California · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6287759

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6274611

Methods and compositions for inhibition of viral replication

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6274598

Methods for treating antibiotic-resistant infections

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6268383

Substituted aromatic compounds for treatment of antibiotic-resistant infections

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 31 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6265380

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6264952

Method for protecting a mammalian host against infection by Brucella

The Board of Regents for Oklahoma State University · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6264957

Product of infectious respiratory syncytial virus from cloned nucleotide sequences

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6254867

Human monoclonal antibodies to the hepatitis B surface antigen

XTL BIOPHARMACEUTICALS LTD. · Granted Tue Jul 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6245362

Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication

Dreluso Pharmazeutika Dr. Elten & Sohn GmbH · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6245737

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6241989

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6235881

Polypeptides encoded by novel HIV-2 proviruses

The Regents of the University of California · Granted Tue May 22 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6229005

DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)